| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.079 | 0.1 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | 0.33 | 0.1 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |